Finch Therapeutics Group's total assets for Q2 2024 were $45.58M, a decrease of -9.02% from the previous quarter. FNCH total liabilities were $31.36M for the fiscal quarter, a 0.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.